Vaccine Development Current Events | Vaccine Development News
|
| Page
1 of
35 |
694 Results |
|
|
|
Sort By:
Page Views | Date |
An HIV Vaccine is within reach
An effective, affordable, and accessible HIV vaccine is 7-10 years away, according to scientists at the Medical Research Council of South Africa, in this week's BMJ. However, its success depends on a complex interplay of politics, science, and public-private partnerships. view more (2002-01-23)
Combating anthrax: Results of study published this month as researchers look for a better vaccine
A new study published this month by a Saint Louis University vaccine researcher scrutinizes what in the future could be an alternative to the presently available anthrax vaccine. view more (2006-08-15)
Universal flu vaccine holds promise
An influenza vaccine that protects against death and serious complications from different strains of flu is a little closer to reality, Saint Louis University vaccine researchers have found. view more (2009-04-28)
The Hunt for a Hepatitis C Vaccine is Under Way at Saint Louis University School of Medicine
Human clinical trials involving investigational vaccines to prevent Hepatitis C are rare. In the fall of 2003 there was a first-ever study at Saint Louis University Center for Vaccine Development, and an earlier small study at Johns Hopkins School of Medicine. view more (2006-05-04)
Novel approach for rapid identification and development of malaria vaccines
Malaria is the world's most frequent parasitic disease, affecting more than 100 countries in the tropical zones, mostly in Africa, and 40% of the world population, with more than a million deaths per year. view more (2007-07-25)
PATH Malaria Vaccine Initiative announces partnership to develop novel malaria vaccine
In a move that promises to expand the types of malaria vaccine candidates in clinical development, the PATH Malaria Vaccine Initiative (MVI) today announced a new partnership with Sanaria Inc., a Maryland company, to accelerate development of a unique malaria vaccine candidate. view more (2006-12-18)
Animal model shows early promise for SARS vaccine (p 1895)
Embargoed 0001 h (London time) 5 December 2003. US authors of a research letter in this week's issue of THE LANCET highlight preliminary findings which could mark an important step in the development of a human vaccine for severe acute respiratory syndrome (SARS). A genetically engineered vaccine was found to be effective in triggering an immune... view more... (2003-12-03)
Ebola DNA vaccine produces immune responses in all fully vaccinated volunteers in Phase 1 trial
Vical Incorporated (Nasdaq:VICL) announced today that an Ebola vaccine candidate administered using Vical's proprietary DNA delivery technology was safe and well tolerated, and produced both antibody and T-cell Ebola-specific responses in all healthy volunteers who received the full 3 doses of vaccine. view more (2006-02-22)
Milestone biodefense publication by Elsevier journal Vaccine
Last week during the 'Vaccines for Biothreats and Emerging and Neglected Diseases Symposium' in Galveston TX, USA, the Elsevier journal Vaccine released a supplement dedicated to vaccines for biodefense. view more (2009-11-20)
Perth researchers to trial bird flu vaccine
Perth researchers have begun a trial to test the effectiveness of a new vaccine to protect against the potentially deadly bird flu. view more (2006-06-29)
How HIV vaccine might have increased odds of infection
In September 2007, a phase II HIV-1 vaccine trial was abruptly halted when researchers found that the vaccine may have promoted, rather than prevented, HIV infection. view more (2008-11-03)
EDCTP welcomes G8 support for HIV/AIDS vaccine development
On 10th June 2004 during this year's summit in Sea Island, Georgia, the G8 Leaders called for the establishment of a Global HIV Vaccine Enterprise: a virtual consortium to accelerate HIV vaccine development by enhancing coordination, information sharing, and global collaboration. The EDCTP is pleased to see this expression of support and... view more... (2004-06-11)
Protecting HIV patients from Hepatitis B virus
Since the transmission of HIV and Hepatitis B virus (HBV) are so similar, individuals infected with one of these viruses are at a significantly increased risk for contracting the other. view more (2007-07-18)
UTMB researchers test new vaccine to fight multiple influenza strains
A universal vaccine effective against several strains of influenza has passed its first phase of testing, according to Dr. Christine Turley of the University of Texas at Galveston. view more (2008-08-22)
New vaccine protects more effectively against tuberculosis
Globally, tuberculosis remains the number one killer in adults. Moreover, multi-drug-resistant tuberculosis strains are on the rise which cannot be treated by first-line drugs. view more (2005-08-29)
Flu news: Study in 8,475 young children points to a more effective influenza vaccine
An intranasal influenza vaccine proved to be more effective than the injectable influenza vaccine in children older than 6 months and younger than 5 years of age. view more (2006-05-02)
Fractional dose of scarce meningitis vaccine may be effective in outbreak control
One fifth of the standard dose of a commonly used meningitis vaccine may be as effective as using the full dose. view more (2008-12-05)
PROMISING RESULTS FOR MALARIA VACCINE (p 1927)
Results of a study from The Gambia in this week's issue of THE LANCET provide evidence of a vaccine that could prevent malaria caused by the micro-organism Plasmodium falciparum. P. falciparum malaria remains a major cause of disease and death in many parts of the tropics, especially in sub-Saharan Africa. The development of an effective vaccine... view more... (2001-12-05)
The case for pneumococcal vaccination of infants
Although the Canadian National Advisory Committee on Immunization recommends that children receive the new pneumococcal vaccine PCV7 beginning at 2 months of age, provincial implementation of the recommendation has been slow. view more (2005-11-08)
University Hospitals Case Medical Center and Case Western Reserve University School of Medicine to Conduct Innovative Smallpox Vaccine Research Study
University Hospitals Case Medical Center (UHCMC) and Case Western Reserve University School of Medicine are part of a nationwide research study to determine the safety and effectiveness of a new smallpox vaccine geared toward adults ages 18 to 34 who have never been vaccinated against the disease. view more (2007-06-04)
|
|
| Page
1 of
35 |
694 Results |
|
|
|
Sort By:
Page Views | Date |
|
